Cite

HARVARD Citation

    Seremet, T. et al. (2019). Anaphylaxis-like reaction to anti-BRAF inhibitor dabrafenib confirmed by drug provocation test. Melanoma research. 29 (1), p. . [Online]. 
  
Back to record